News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Carvana recently upsized and priced a US$1.66 billion Senior Secured Term Loan B, maturing in seven years and priced at one-month Term SOFR plus 2.25%, to redeem in full its 9.00% Senior Secured Notes due 2030 and cut annual cash interest expense by about …
Sharemaestro market context Price above Trend Line 52 weeks -5.4%Pharvaris (NASDAQ:PHVS) recently hit a new 52-week high of $36.65, with a current market capitalization of $2.38 billion, despite missing its latest quarterly earnings estimate. Analyst sentiment is generally positive with a "Moderate Buy" consensus and an average price target of $50.08, though some …
Citizens has increased its price target for Pharvaris B.V. to $75.00 from $74.00, maintaining a Market Outperform rating, due to ongoing trial progress. The company's stock has surged 70% in the past year, and key Phase 3 CHAPTER-3 data is expected this quarter. Pharvaris …
Shares of Marvell Technology, MACOM, Micron, Western Digital, and Semtech surged following upbeat earnings reports and bullish forecasts from key industry players, signaling strong demand for artificial intelligence technology. The rally was driven by positive results from AI-related firms like Super Micro Computer and …
Benchmark has increased its price target for Harvard Bioscience (NASDAQ:HBIO) to $7.50 from $6.00, maintaining a Speculative Buy rating after the company surpassed second-quarter revenue guidance. The company reported $22.7 million in revenue, exceeding both management's and consensus estimates, and subsequently raised its full-year …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Carvana's updated analyst fair value estimate has shifted from about US$89.83 to US$82.83, landing within a tighter band that now clusters many targets between US$70 and US$100. …
Sharemaestro market context Price above Trend Line 52 weeks -5.4%Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Carvana's new loan matters for stockholders Carvana (CVNA) has secured a new US$1.66b Senior Secured Term Loan B facility, giving the company room …
Sharemaestro market context Price above Trend Line 52 weeks -5.4%Marvell Technology (NASDAQ:MRVL) shares increased by 2.2% following investor interest in its AI infrastructure portfolio, an expanded NVIDIA alliance, and potential demand from Microsoft’s custom-chip program. Despite a broadly bullish "Moderate Buy" consensus from analysts, the stock faces risks due to its elevated valuation …
Pharvaris (NASDAQ:PHVS) experienced unusually high trading volume, with 487,339 shares traded, marking a 60% increase from the previous session. The stock closed at $34.48, and analysts maintain a "Moderate Buy" rating with an average price target of $50.08 despite the company missing quarterly EPS …
BioHarvest Sciences presented at Canaccord Genuity's 46th Annual Growth Conference, detailing its plant cell culture technology, commercial sales, and expansion into enterprise manufacturing. The company highlighted strong momentum in its consumer supplement line, VINIA, and early traction in its CDMO business, alongside plans for …
BioHarvest Sciences, a plant cell culture company, has secured a $20–30 million fragrance deal leveraging its patented, non-GMO technology. The company projects revenues of $37–40 million this year and anticipates achieving profitability next year, alongside planned expansions. This information is based on their recent …
Marvell Technology Inc. (MRVL) saw a 4.01% increase in its stock price, driven by bullish sentiment surrounding its AI data center infrastructure portfolio and new product introductions at the Flash Memory Summit. The company's commitment to invest $250 million in expanding Indian R&D facilities …
As the consumer landscape evolves, investors must choose between high-growth disruptors and established dividend payers. We compare Carvana (NYSE:CVNA) and Home Depot (NYSE:HD) to see which stock offers the best path forward. Carvana focuses on transforming the car-buying experience through an online-only model, while …
Sharemaestro market context Price above Trend Line 52 weeks -5.4%Marvell Technology Inc. (MRVL) shares surged by 5.04% due to strong demand for AI chips and favorable analyst upgrades, further bolstered by the launch of an expanded AI-focused memory infrastructure portfolio. This new suite, including the Bravera SC6 PCIe 6.0 SSD controller, Structera X …
Reduces cash interest expense by approximately $45 million per year on a leverage-neutral basis PHOENIX, August 12, 2026--(BUSINESS WIRE)--Carvana (NYSE: CVNA), the leading e-commerce platform for buying and selling cars, today announced the successful upsize and pricing of a Senior Secured Term Loan B …
Sharemaestro market context Price above Trend Line 52 weeks -5.4%Marvell Technology Inc. (MRVL) stock surged by 4.16% due to bullish sentiment driven by its new AI-focused memory infrastructure products, including the Bravera SC6 PCIe 6.0 SSD controller, Structera X CXL memory expansion platform, and Photonic Fabric optical shared-memory solutions. The company is investing …
This article provides a detailed AI-driven analysis of Pharvaris N.v. (NASDAQ: PHVS), highlighting a strong near-term sentiment moving towards a long-term positive bias. It outlines three institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis and specific entry, target, and stop-loss …
Marvell Technology, Inc. announced a $250 million investment in India over the next three years to expand its technology, talent, and infrastructure capabilities. This investment coincides with Marvell celebrating 20 years of innovation in India and aims to double its headcount, expand its Bangalore …
Pharvaris reported its Q2 2026 financial results, with cash and cash equivalents of €318 million, providing a financial runway into 2028. The company is advancing deucrictibant for bradykinin-mediated angioedema, with topline data from the pivotal Phase 3 CHAPTER-3 study expected in Q3 2026, and …
The Manufacturers Life Insurance Company significantly reduced its stake in Pharvaris N.V. by 44.7% in Q1 2026, selling 35,695 shares. Despite this, analysts maintain a "Moderate Buy" rating with an average price target of $50.08, while company insiders have recently sold a substantial number …
Annex Advisory Services LLC reduced its stake in Marvell Technology (NASDAQ:MRVL) by 62.9% in the second quarter, selling 35,698 shares. Despite this, institutional investors collectively own 83.51% of the semiconductor company's stock, and analysts maintain a "Moderate Buy" consensus rating with an average price …
Harvard Bioscience (HBIO) reported its Q2 2026 financial results, showing a narrower-than-expected adjusted loss of $0.14 per share, beating analyst estimates. Revenue increased by 10.7% to $22.7 million. The company attributes this improvement to steady demand for its laboratory equipment and instruments, reflecting stabilization …
Harvard Bioscience, Inc. (HBIO) published its slide deck in conjunction with its Q2 2026 earnings call. The company reported an EPS of -$0.14, beating estimates by $0.07, and revenue of $22.73M, which was an 11.13% year-over-year increase and beat by $1.28M. This article provides …
Search by ticker symbol or company name and select a result to open its chart.